Glioblastoma: open trials in Singapore

• NCT06914128

  A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  Trial Treatment · Phase 1/2 · Bayer

  National Cancer Center Singapore - Oncology Department, Singapore · National University Hospital Medical Centre, Singapore · Icon Cancer Centre, Singapore

  Registry updated 2026-10-28

• NCT04094610

  A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  National University Hospital, Singapore · KK Women's and Children's Hospital, Singapore

  Registry updated 2026-09-25

• NCT06894225

  Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature

  Trial Treatment · Phase 2 · National Neuroscience Institute

  National Neuroscience Institute, Singapore

  Registry updated 2026-09-04

• NCT03175224

  APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  Trial Treatment · Phase 2 · Apollomics Inc.

  National Cancer Centre Singapore, Singapore

  Registry updated 2025-06-27

All Glioblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error